A biochemistry postgrad with a passion for poetry and science, Prayagraj's Shakti Dubey credits her family, teachers and her ...

Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND) application for RN1871, a small interfering RNA (siRNA) drug ...

The following is a summary of "ADORA2B promotes proliferation and migration in head and neck squamous cell carcinoma and is ...

CHICAGO, IL—An investigational agent given by subcutaneous injection can drastically reduce levels of lipoprotein (a), with ...

In what could be seen as a bellwether for the pharmaceutical industry's sweeping shift toward localised manufacturing—spurred ...

China NMPA approves Rona Therapeutics’ IND application for RN1871, a novel AGT-targeting siRNA drug for hypertension: Shanghai, China Tuesday, April 22, 2025, 18:00 Hrs [IST] Ro ...

In particular, hedge fund managers, using their vast resources and analytical capabilities, are more receptive to such ...

By leveraging siRNA technology to treat disease fundamentally, RN1871 achieves sustained efficacy with less dosing frequency. We look forward to bringing this innovative therapy to hypertension ...

Akka Nasan ibsetti waggaa wagggaan wantoonni caccabaa dhagaa fakkaatan hawaa keessaa gara pilaaneetii keenya Dacheetti ni ...

Itoophiyaa fi waraana- Gaa'ila Hiikkaa barbaadan jechuun tibbana kitaaba isaanii kan maxxansiisan Let Jeneraal Yohaannis ...